Insulet Corporation (BMV:PODD)

Market Cap	297.58B -26.2%
Revenue (ttm)	48.75B +30.7%
Net Income	4.45B -40.9%
EPS	62.65 -39.8%
Shares Out	n/a
PE Ratio	66.89
Forward PE	39.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6
Average Volume	185
Open	4,402.00
Previous Close	6,038.64
Day's Range	4,402.00 - 4,402.00
52-Week Range	4,402.00 - 6,170.25
Beta	n/a
RSI	44.69
Earnings Date	Feb 18, 2026

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is cont...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 3,900
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PODD

Financial Performance

In 2025, Insulet's revenue was $2.71 billion, an increase of 30.73% compared to the previous year's $2.07 billion. Earnings were $247.10 million, a decrease of -40.93%.

Financial numbers in USD